There is a vast literature about circulating biomarkers of AD and APOE genotypes in cerebral spinal fluid (CSF) and blood (Huynh & Mohan, 2017; Soares et al., 2012), but past analyses have been limited by panels of small numbers of biomarkers. This evidence concerns the gene APOE and Alzheimer disease.